| VRDN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VRDN shares outstanding history going back to 11/13/2020:
Also see: VRDN Market Cap History VRDN YTD Return |
As of 5/1/2026 Viridian Therapeutics has 103.07 million VRDN shares outstanding. Investors often track the VRDN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows VRDN share count trends over time, with 22 historical shares outstanding datapoints presented, dating back to 11/13/2020.

| VRDN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VRDN shares outstanding history going back to 11/13/2020:
Also see: VRDN Market Cap History VRDN YTD Return |
| VRDN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
VRDN Historical Shares Outstanding: +82.01% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| VRDN Stock Price Chart |
| About Viridian Therapeutics Inc |
| Viridian Therapeutics, Inc. is a biopharmaceutical company focused on engineering and developing potential medicines for patients with serious and rare diseases. Co. is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). Co. is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. It is focused on advancing VRDN-001 as a potential intravenous therapy followed by VRDN-003 as a potential subcutaneous therapy for the treatment of TED. We show 22 historical shares outstanding datapoints in our coverage of VRDN's shares outstanding history. Understanding the changing numbers of VRDN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VRDN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VRDN by allowing them to research VRDN shares outstanding history as well as any other stock in our coverage universe. |
| VRDN Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| VRDN Share Performance |
| Shares Outstanding Peers |
| Viridian Therapeutics (VRDN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
VREX Shares Outstanding History VRML Shares Outstanding History VRPX Shares Outstanding History VRTX Shares Outstanding History VRX Shares Outstanding History VSAR Shares Outstanding History VSTM Shares Outstanding History VTGN Shares Outstanding History VTL Shares Outstanding History VTRS Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.